Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression

被引:83
|
作者
Niciu, Mark J. [1 ]
Shovestul, Bridget J. [1 ]
Jaso, Brittany A. [2 ]
Farmer, Cristan [1 ]
Luckenbaugh, David A. [3 ]
Brutsche, Nancy E. [1 ]
Park, Lawrence T. [1 ]
Ballard, Elizabeth D. [1 ]
Zarat, Carlos A., Jr. [1 ]
机构
[1] NIMH, NIH, Expt Therapeut & Pathophysiol Branch, Bldg 10 CRC,10 Ctr Dr,Unit 7 Southeast, Bethesda, MD 20892 USA
[2] Univ Miami, Dept Psychol, POB 248185-0751, Coral Gables, FL 33124 USA
[3] NIH, Off Equ Divers & Inclus, 2115 E Jefferson St, Rockville, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Dissociation; Ketamine; Depression; METHYL-D-ASPARTATE; ADD-ON TRIAL; MAJOR DEPRESSION; BIPOLAR DEPRESSION; PREFRONTAL CORTEX; RANDOMIZED-TRIAL; DOUBLE-BLIND; ANTAGONIST; GLUTAMATE; BLOCKADE;
D O I
10.1016/j.jad.2018.02.049
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Ketamine induces rapid and robust antidepressant effects, and many patients also describe dissociation, which is associated with antidepressant response. This follow-up study investigated whether antidepressant efficacy is uniquely related to dissociative symptom clusters. Methods: Treatment-resistant patients with major depressive disorder (MDD) or bipolar disorder (BD) (n=126) drawn from three studies received a single subanesthetic (0.5 mg/kg) ketamine infusion. Dissociative effects were measured using the Clinician-Administered Dissociative States Scale (CADSS). Antidepressant response was measured using the 17-item Hamilton Depression Rating Scale (HAM-D). A confirmatory factor analysis established the validity of CADSS subscales (derealization, depersonalization, amnesia), and a general linear model with repeated measures was fitted to test whether subscale scores were associated with antidepressant response. Results: Factor validity was supported, with a root mean square error of approximation of .06, a comparative fit index of .97, and a Tucker-Lewis index of .96. Across all studies and timepoints, the depersonalization subscale was positively related to HAM-D percent change. A significant effect of derealization on HAM-D percent change was observed at one timepoint (Day 7) in one study. The amnesia subscale was unrelated to HAM-D percent change. Limitations: Possible inadequate blinding; combined MDD/BD datasets might have underrepresented ketamine's antidepressant efficacy; the possibility of Type I errors in secondary analyses. Conclusions: From a psychometric perspective, researchers may elect to administer only the CADSS depersonalization subscale, given that it was most closely related to antidepressant response. From a neurobiological perspective, mechanistic similarities may exist between ketamine-induced depersonalization and antidepressant response, although off-target effects cannot be excluded.
引用
收藏
页码:310 / 315
页数:6
相关论文
共 50 条
  • [1] Features of Dissociation Differentially Predict Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
    Niciu, Mark
    Shovestul, Bridget
    Jaso, Brittany
    Farmer, Cristan
    Luckenbaugh, David
    Park, Lawrence
    Ballard, Elizabeth
    Zarate, Carlos
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S564 - S564
  • [2] Dissociative symptoms predict antidepressant response after infusion of ketamine in treatment-resistant depression
    Echegaray, M. V. F.
    Mello, R.
    Correia-Melo, F. S.
    Leal, G. C.
    Jesus-Nunes, A. P.
    Vieira, F.
    Fontes, A. T. C.
    Beanes, G.
    Magnavita, G.
    Bandeira, I. D.
    Lacerda, A. L. T.
    Quarantini, L. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S321 - S322
  • [3] Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
    Del Sant, L. C.
    Magalhaes, E.
    Lucchese, A. C.
    Palhares Alves, H. N.
    Sarin, L. M.
    Del Porto, J. A.
    Tavares de lacerda, A. L.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S525 - S526
  • [4] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    James W. Murrough
    Le-Ben Wan
    Brian Iacoviello
    Katherine A. Collins
    Carly Solon
    Benjamin Glicksberg
    Andrew M. Perez
    Sanjay J. Mathew
    Dennis S. Charney
    Dan V. Iosifescu
    Katherine E. Burdick
    [J]. Psychopharmacology, 2014, 231 : 481 - 488
  • [5] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    Murrough, James W.
    Wan, Le-Ben
    Iacoviello, Brian
    Collins, Katherine A.
    Solon, Carly
    Glicksberg, Benjamin
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    Burdick, Katherine E.
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (03) : 481 - 488
  • [6] Acute and Prolonged Antidepressant Effects of Ketamine in Treatment-Resistant Depression
    Phillips, Jennifer
    Birmingham, Meagan
    Hatchard, Taylor
    Norris, Sandhaya
    Talbot, Jeanne
    Ortiz, Abigail
    Blier, Pierre
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S189 - S190
  • [7] Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression
    de la Salle, Sara
    Phillips, Jennifer L.
    Blier, Pierre
    Knott, Verner
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 115
  • [8] Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
    Park, Minkyung
    Newman, Laura E.
    Gold, Philip W.
    Luckenbaugh, David A.
    Yuan, Peixiong
    Machado-Vieira, Rodrigo
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 84 : 113 - 118
  • [9] Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
    Cornwell, Brian R.
    Salvadore, Giacomo
    Furey, Maura
    Marquardt, Craig A.
    Brutsche, Nancy E.
    Grillon, Christian
    Zarate, Carlos A., Jr.
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 72 (07) : 555 - 561
  • [10] Structural and Connectomic Brain Features of Treatment Resistant Depression and Antidepressant Response to Ketamine
    Murrough, James
    Van Dam, Nicholas
    Grehl, Mora
    Tan, Aaron
    Morris, Laurel
    [J]. BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S55 - S55